Affordable Access

deepdyve-link
Publisher Website

Lung microbiology and exacerbations in COPD.

Authors
  • Beasley, Victoria
  • Joshi, Priya V
  • Singanayagam, Aran
  • Molyneaux, Philip L
  • Johnston, Sebastian L
  • Mallia, Patrick
Type
Published Article
Journal
International journal of chronic obstructive pulmonary disease
Publication Date
Jan 01, 2012
Volume
7
Pages
555–569
Identifiers
DOI: 10.2147/COPD.S28286
PMID: 22969296
Source
Medline
Keywords
License
Unknown

Abstract

Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory condition in adults and is characterized by progressive airflow limitation that is not fully reversible. The main etiological agents linked with COPD are cigarette smoking and biomass exposure but respiratory infection is believed to play a major role in the pathogenesis of both stable COPD and in acute exacerbations. Acute exacerbations are associated with more rapid decline in lung function and impaired quality of life and are the major causes of morbidity and mortality in COPD. Preventing exacerbations is a major therapeutic goal but currently available treatments for exacerbations are not very effective. Historically, bacteria were considered the main infective cause of exacerbations but with the development of new diagnostic techniques, respiratory viruses are also frequently detected in COPD exacerbations. This article aims to provide a state-of-the art review of current knowledge regarding the role of infection in COPD, highlight the areas of ongoing debate and controversy, and outline emerging technologies and therapies that will influence future diagnostic and therapeutic pathways in COPD.

Report this publication

Statistics

Seen <100 times